Mylan attempts to allay India's Agila concerns
This article was originally published in Scrip
Executive Summary
Mylan has put forth a set of facts and projections to assuage the Indian government's concerns over its acquisition of Strides Arcolab's injectables arm, Agila Specialties, suggesting that is keen not just to build its domestic presence but also to invest in people and manufacturing capacity in the country.